Dr. Birkhofer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bristol-Myers Squibb
Route 206 and Provinceline Road
Princeton, NJ 08540Phone+1 609-252-3244
Education & Training
New York Medical CollegeClass of 1983
Publications & Presentations
PubMed
- 450 citationsCTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgarisJudith R. Abrams, Mark Lebwohl, Cynthia Guzzo, Brian V. Jegasothy, Michael T. Goldfarb
The Journal of Clinical Investigation. 1999-05-01 - 44 citationsThe effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythimidine (AZT)-mediated biochemical and cytotoxic effec...Kapil N. Bhalla, M. Birkhofer, Simon Grant, G. Graham
Experimental Hematology. 1989-01-01 - 46 citationsA Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult MenDiptee A. Gajjar, Frank LaCreta, Howard Uderman, Georgia Kollia, Glenn F. Duncan
Pharmacotherapy. 2000-06-01
Press Mentions
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (Trifluridine and Tipiracil) Published in JAMA OncologyOctober 10th, 2019
Taiho Oncology and Servier Present LONSURF® (Trifluridine and Tipiracil) Data at the 2019 ASCO Annual MeetingJune 3rd, 2019
NCCN Awards Grants to Investigators to Study Trifluridine and Tipiracil in Various CancersMarch 14th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
